SCHEMBL109479

SCHEMBL109479

COc1ccc(Br)cc1.[MgH2]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.65
CA2 P00918 2/20 0.65
CA7 P43166 2/20 0.65
CA9 Q16790 2/20 0.65
CA12 O43570 1/20 0.65
CA14 Q9ULX7 1/20 0.65
RAB9A P51151 4/20 0.64
MAPT P10636 3/20 0.64
MAPK1 P28482 3/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
LMNA P02545 2/20 0.64
NPSR1 Q6W5P4 2/20 0.64
RXFP1 Q9HBX9 1/20 0.64
MAOA P21397 2/20 0.57
MAOB P27338 2/20 0.57
NPC1 O15118 3/20 0.55
GAA P10253 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
ACHE P22303 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5345194 0.97 RAB9A (0.61) CA1CA2CA7CA9CA12
SCHEMBL9301 0.97
SCHEMBL10605468 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
SCHEMBL5466009 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
SCHEMBL30056198 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
Bromomethane SCHEMBL9702151 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
Magnesium SCHEMBL31191739 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
Phosphine SCHEMBL9754815 0.94 CA1 (0.65) CA1CA2CA7CA9CA12
Bromide SCHEMBL5345195 0.92 RAB9A (0.61) CA1CA2CA7CA9CA12
Methyl Alcohol SCHEMBL27852458 0.92 MEN1 (0.68) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118908996-A A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond 烟台大学 2024-11-08 CN claimed
CN-114835755-B Catalyst of metal complex of biphosphinamide in catalytic polymerization, and preparation method 常州德能新材料有限公司 2023-08-18 CN claimed
WO-2023124996-A1 SULFUR-CONTAINING CHIRAL BRIDGED METALLOECENE COMPOUND, PREPARATION THEREOF, AND APPLICATION 中国石油天然气股份有限公司 2023-07-06 WO claimed
CN-113801147-B Hydrazone-based Zn (II) complex photochromic material and preparation and application thereof 南京邮电大学 2022-06-14 CN claimed
CN-113897701-A Production method for preparing PET (polyethylene terephthalate) fibers by using regenerated plastic bottles 界首市金吴再生资源利用有限公司 2022-01-07 CN claimed
CN-113801147-A Hydrazone-based Zn (II) complex photochromic material and preparation and application thereof 南京邮电大学 2021-12-17 CN claimed
CN-113277972-A Method for synthesizing hole transport material based on diphenylamine substituted carbazole fluorene hybridization and application of hole transport material in perovskite solar cell 云南大学 2021-08-20 CN claimed
CN-112279820-B Preparation method of 2- (4-methoxyphenyl) -3-hydroxy-2, 3-dihydro-1, 5-benzothiazepine 苏州开元民生科技股份有限公司 2021-04-02 CN claimed
CN-112279820-A Preparation method of 2- (4-methoxyphenyl) -3-hydroxy-2, 3-dihydro-1, 5-benzothiazepine 苏州开元民生科技股份有限公司 2021-01-29 CN claimed
CN-108503652-B Chemical total synthesis preparation method of crotonaldehyde diterpene Prostratin 西安交通大学 2020-08-28 CN claimed
US-20160272573-A1 NOVEL PROCESS FOR TOTAL SYNTHESIS OF VENLAFAXINE COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-09-22 US claimed
CN-103435523-B The preparation method of the fluoro-cyclopropylamine tosilate of (1R, 2S)-2- Suzhou Chukai Pharmaceutical Technology Co., Ltd. (CN) 2015-12-23 CN claimed
CN-103435523-A Preparation method for (1R, 2S)-2-fluoro-cyclopropanamine tosylate SUZHOU CHUKAI PHARMATECH CO LTD 2013-12-11 CN claimed
CN-102066002-A In situ olefin polymerization catalyst system PROMERUS LLC 2011-05-18 CN claimed
CN-100548950-C Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2009-10-14 CN claimed
CN-1759084-A Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2006-04-12 CN claimed
US-6200503-B1 LOW-LOSS AND HIGH-BANDWIDTH OPTICAL FIBER CABLE THAT IS FLEXIBLE, RAPID, INEXPENSIVE, AND SIMPLE TO PRODUCE. KT HOLDINGS, LLC 2001-03-13 US claimed
EP-0958254-A4 GRADED INDEX POLYMER OPTICAL FIBERS AND PROCESS FOR MANUFACTURE THEREOF KATOOT MOHAMMAD W (US) 2001-01-10 EP claimed
EP-0958254-A1 GRADED INDEX POLYMER OPTICAL FIBERS AND PROCESS FOR MANUFACTURE THEREOF Katoot, Mohammed W. (US) 1999-11-24 EP claimed
WO-1998011287-A1 GRADED INDEX POLYMER OPTICAL FIBERS AND PROCESS FOR MANUFACTURE THEREOF KATOOT MOHAMMAD W (US) 1998-03-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272573-A1 NOVEL PROCESS FOR TOTAL SYNTHESIS OF VENLAFAXINE CYP4F3, CYP3A5, TPH2 CA1 4509/4885CA2 4465/4885CA7 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.